422 related articles for article (PubMed ID: 11864992)
21. Proteasome inhibitors: valuable new tools for cell biologists.
Lee DH; Goldberg AL
Trends Cell Biol; 1998 Oct; 8(10):397-403. PubMed ID: 9789328
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of renal tubular cell hypertrophy: mitogen-induced suppression of proteolysis.
Franch HA; Curtis PV; Mitch WE
Am J Physiol; 1997 Sep; 273(3 Pt 1):C843-51. PubMed ID: 9316404
[TBL] [Abstract][Full Text] [Related]
23. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
[TBL] [Abstract][Full Text] [Related]
24. Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway.
Melman L; Geuze HJ; Li Y; McCormick LM; Van Kerkhof P; Strous GJ; Schwartz AL; Bu G
Mol Biol Cell; 2002 Sep; 13(9):3325-35. PubMed ID: 12221136
[TBL] [Abstract][Full Text] [Related]
25. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
[TBL] [Abstract][Full Text] [Related]
26. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
Smith CJ; Berry DM; McGlade CJ
J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
[TBL] [Abstract][Full Text] [Related]
27. c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route.
de Melker AA; van der Horst G; Calafat J; Jansen H; Borst J
J Cell Sci; 2001 Jun; 114(Pt 11):2167-78. PubMed ID: 11493652
[TBL] [Abstract][Full Text] [Related]
28. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.
Soubeyran P; Kowanetz K; Szymkiewicz I; Langdon WY; Dikic I
Nature; 2002 Mar; 416(6877):183-7. PubMed ID: 11894095
[TBL] [Abstract][Full Text] [Related]
29. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
[TBL] [Abstract][Full Text] [Related]
30. The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor.
Vecchione A; Marchese A; Henry P; Rotin D; Morrione A
Mol Cell Biol; 2003 May; 23(9):3363-72. PubMed ID: 12697834
[TBL] [Abstract][Full Text] [Related]
31. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
32. Delayed and sustained activation of p42/p44 mitogen-activated protein kinase induced by proteasome inhibitors through p21(ras) in PC12 cells.
Hashimoto K; Guroff G; Katagiri Y
J Neurochem; 2000 Jan; 74(1):92-8. PubMed ID: 10617109
[TBL] [Abstract][Full Text] [Related]
33. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation.
Bays NW; Gardner RG; Seelig LP; Joazeiro CA; Hampton RY
Nat Cell Biol; 2001 Jan; 3(1):24-9. PubMed ID: 11146622
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
35. Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.
Jockers R; Angers S; Da Silva A; Benaroch P; Strosberg AD; Bouvier M; Marullo S
J Biol Chem; 1999 Oct; 274(41):28900-8. PubMed ID: 10506134
[TBL] [Abstract][Full Text] [Related]
36. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.
Jeffers M; Taylor GA; Weidner KM; Omura S; Vande Woude GF
Mol Cell Biol; 1997 Feb; 17(2):799-808. PubMed ID: 9001234
[TBL] [Abstract][Full Text] [Related]
37. c-Cbl directs EGF receptors into an endocytic pathway that involves the ubiquitin-interacting motif of Eps15.
de Melker AA; van der Horst G; Borst J
J Cell Sci; 2004 Oct; 117(Pt 21):5001-12. PubMed ID: 15383614
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin is part of the retrovirus budding machinery.
Patnaik A; Chau V; Wills JW
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13069-74. PubMed ID: 11087861
[TBL] [Abstract][Full Text] [Related]
39. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.
Hall AB; Jura N; DaSilva J; Jang YJ; Gong D; Bar-Sagi D
Curr Biol; 2003 Feb; 13(4):308-14. PubMed ID: 12593796
[TBL] [Abstract][Full Text] [Related]
40. cbl-b inhibits epidermal growth factor receptor signaling.
Ettenberg SA; Keane MM; Nau MM; Frankel M; Wang LM; Pierce JH; Lipkowitz S
Oncogene; 1999 Mar; 18(10):1855-66. PubMed ID: 10086340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
